Significant association of periodontal disease with anti-citrullinated peptide antibody in a Japanese healthy population - The Nagahama study. by Terao, Chikashi et al.
Title
Significant association of periodontal disease with anti-
citrullinated peptide antibody in a Japanese healthy population
- The Nagahama study.
Author(s)
Terao, Chikashi; Asai, Keita; Hashimoto, Motomu; Yamazaki,
Toru; Ohmura, Koichiro; Yamaguchi, Akihiko; Takahashi,
Katsu; Takei, Noriko; Ishii, Takanori; Kawaguchi, Takahisa;
Tabara, Yasuharu; Takahashi, Meiko; Nakayama, Takeo;
Kosugi, Shinji; Sekine, Akihiro; Fujii, Takao; Yamada, Ryo;
Mimori, Tsuneyo; Matsuda, Fumihiko; Bessho, Kazuhisa




© 2015 Elsevier Ltd. NOTICE: this is the author's version of a
work that was accepted for publication in Journal of
Autoimmunity. Changes resulting from the publishing process,
such as peer review, editing, corrections, structural formatting,
and other quality control mechanisms may not be reflected in
this document. Changes may have been made to this work
since it was submitted for publication. A definitive version was





Significant association of periodontal disease with anti-citrullinated peptide antibody in a 
Japanese healthy population –the Nagahama study. 
 
 
Chikashi Terao MD., PhD.1,2,8, Keita Asai DDS.3,8, Motomu Hashimoto MD., PhD.4, Toru 
Yamazaki DDS. Ph.D., MPH3, Koichiro Ohmura MD., PhD.2, Akihiko Yamaguchi DDS. Ph.D.3, 
Katsu Takahashi DDS. Ph.D.3, Noriko Takei5, Takanori Ishii5, Takahisa Kawaguchi BA.1, 
Yasuharu Tabara PhD.1, Meiko Takahashi PhD.1, Takeo Nakayama MD., PhD.6, Shinji Kosugi 
MD., PhD.7, Akihiro Sekine7, Takao Fujii MD., PhD.4, Ryo Yamada MD., PhD.1, Tsuneyo 
Mimori MD., PhD.2, Fumihiko Matsuda PhD.1, Kazuhisa Bessho DDS. Ph.D.3 on behalf of the 
Nagahama Study Group 
 
1Center for Genomic Medicine, 2Department of Rheumatology and Clinical Immunology, 
3Department of Oral and Maxillofacial Surgery, 4Department of the Control for Rheumatic 
Diseases, 8EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan 
606-8507, 5The Lion Foundation for dental health, Tokyo 130-0004, Japan, 6Department of 
Health Informatics, 7Department of Medical Ethics and Medical Genetics, Kyoto University 




Correspondence and reprint requests should be addressed to: 
Chikashi Terao at Center for Genomic Medicine, Kyoto University Graduate School of 
Medicine, Kyoto 606-8507, Japan, Phone number: +81753667405, Fax number: +81757514167, 
E-mail address: a0001101@kuhp.kyoto-u.ac.jp 
 
Total number of pages: 18 
Total number of Figures: 1 





Anti-citrullinated peptide antibody (ACPA) is a highly specific autoantibody to rheumatoid 
arthritis (RA). Recent studies have revealed that periodontal disease (PD) is closely associated 
with RA and production of ACPA in RA. Analyses of associations between PD and ACPA 
production in a healthy population may deepen our understandings. Here, we analyzed a total of 
9,554 adult healthy subjects. ACPA and IgM-rheumatoid factor (RF) was quantified and PD 
status was evaluated using the number of missing teeth (MT), the Community Periodontal Index 
(CPI) and Loss of Attachment (LA) for these subjects. PD status was analyzed for its 
association with the positivity and categorical levels of ACPA and RF conditioned for covariates 
which were shown to be associated with PD, ACPA or RF. As a result, all of MT, CPI and LA 
showed suggestive or significant associations with positivity (p=0.024, 0.0042 and 0.037, 
respectively) and levels of ACPA (p≤0.00031), but none of the PD parameters were associated 
with those of RF. These association patterns were also observed when we analyzed 6,206 
non-smokers of the participants. The significant associations between PD parameters and 
positivity and levels of ACPA in healthy population support the fundamental involvement of PD 
with ACPA production. 
Keywords: epidemioloical study, periodontal disease, ACPA, RF, association study, rheumatoid 
arthritis 
1.Introduction 
Rheumatoid arthritis (RA) is the most common cause of adult chronic autoimmune arthritis in 
the world affecting 0.5 to 1.0% of the population. Environmental and genetic factors have been 
shown to be important for the onset of RA[1, 2]. Anti-citrullinated peptide antibody (ACPA) 
and rheumatoid factor (RF) are autoantibodies frequently found in patients with RA[3-5]. ACPA 
is a highly specific autoantibody to RA[5].  Smoking is an established environmental factor 
which is associated with RA development and ACPA positivity in RA[6, 7]. Although the 
pathological function of ACPA is not fully established, recent studies have revealed that some 
fractions of ACPA is pathogenic in experimental animal models[8]. 
The association between periodontal disease (PD) and RA development has been reported and 
PD is an emerging risk factor for RA[9]. PD affects more than 20% of the general population 
and its chronic inflammation leads to the damage of oral tissues including periodontal ligaments, 
resulting in periodontal pockets and ultimately, tooth loss[10]. Patients with RA were reported 
to have higher frequency of PD and severer PD than controls including patients with 
osteoarthirits[11, 12]. Since Porphyromonas.gingivalis (P gingivalis), a bacterial flora of PD, is 
the only microorganism ever found with citrullination enzyme peptidylarginine deiminase 
(PAD)[13], it has been hypothesized that PD is associated with the production of ACPA via 
citrullination of proteins by P gingivalis and the resultant RA[14, 15]. However, it is difficult to 
assess whether PD is a cause or result of RA when analyzing data of patients with RA. In spite 
of a previous study reporting the presence of PD in patients with early RA naïve to DMARDs 
treatment[16], the possibility is undeniable that decreased activity of daily living due to early 
RA would lead to PD. Since RF and ACPA can be observed in patients with other diseases and 
even in healthy populations, studies should extend to healthy individuals to confirm the 
correlation between PD and production of RA-related autoantibodies and provide a clue to the 
causality of PD on the autoantibody production.  
Recently, we reported detailed distribution and correlates of ACPA and RF using the data of 
the Nagahama Study, a Japanese community based prospective cohort[17]. Here, we analyzed 
the associations between PD status and RA-related autoantibodies especially ACPA using the 
data of the Nagahama study. 
 
2.Materials and Methods 
2.1Study Subjects 
A total of 9,804 subjects were registered in the Nagahama Study. 201 subjects were excluded 
due to having or being suspected to have autoimmune diseases. 28 subjects were excluded due 
to insufficient data. As a result, 9,575 subjects in the Nagahama Study who did not have 
connective tissue diseases[17] were selected for the current study. The details of sample 
selections were described in the previous study[17]. The current study was approved by the 
Ethics Committee, Kyoto University Graduate School and Faculty of Medicine and written 
informed consent was obtained from each participant. 
 
2.2ACPA and RF quantification. 
The details of the measurement of ACPA and RF were described previously[17]. Briefly, the 
2nd generation anti-CCP antibody was quantified as ACPA by MESACUP CCP ELISA kit 
(Medical and Biological Laboratories Co., Ltd, Nagoya, Japan).  IgM-RF was quantified as RF 
by latex turbidimetric immunoassay, IATRO-RF II (Mitsubishi Kagaku Medience, Co., Tokyo, 
Japan).  The cut-off levels of the autoantibodies were set according to the manufacturer’s 
instructions (ACPA<4.5U/ml, RF≤20IU/ml). The lower measuring limit of ACPA and RF were 
0.6U/ml and 1IU/ml, respectively. RF levels of all subjects were within the measuring limit 
(≥1IU/ml). ACPA and RF were measured for all of the participants in the current study. 
 
2.3PD parameters 
Subjects in the Nagahama Study were evaluated by dentists for PD status. The number of 
missing teeth (MT), the Community Periodontal Index (CPI) and Loss of Attachment (LA) were 
evaluated as PD parameters for 9,554 out of 9,575 subjects (Supplementary Table 1). LA and 
CPI were evaluated in the jaw sextants according to the WHO recommendations where the 
maximum score of LA and CPI was 4. Since we aimed to assess systemic PD and were not 
focusing on localized inflammation, we calculated the average score of LA or CPI in the 
sextants. When subjects had fractions of sextants we could not evaluate due to lack of teeth, a 
score of 4 was given to the regions. 
 
2.4Statistical Analysis 
Logistic regression analysis was performed to evaluate the effects of PD parameters on ACPA 
and RF positivity. Linear or Poisson regression analyses were applied to investigate the 
association between PD parameters and levels or categorical levels of ACPA and RF. Positivity, 
levels and categorical levels of ACPA and RF were used as dependent variables, and age, sex, 
smoking status, body mass index (BMI), alcohol drinking status, history of diabetes mellitus 
(DM), usage of insulin and anti-hyperglycaemic medications and the current working status 
were used as covariates based on the previous studies[17-19]. Ex- and current smokers were 
classified as smokers. Those who do not drink alcohol at all were regarded as non-drinkers. The 
current working status consists of three categories, namely, full-time worker, part-time worker 
and unemployed. Detailed distributions of the covariates are shown in Table 1. When levels of 
ACPA and RF were analyzed, the levels were natural logarithm-transformed and subjects whose 
ACPA levels were under and over the measuring limit of the kit (0.6-100U/ml) were given 0.5 
and 100U/ml of ACPA levels, respectively, for calculation.   
When categorical levels of ACPA and RF were analyzed, levels under the measuring limit of 
ACPA and the lowest levels of RF were set as 0, levels of ACPA and RF which were lower than 
the cut-off levels and higher than category 0 were set as 1, levels higher than the cut-off levels 
and lower than three times the cut-off level were set as 2, levels higher than three times the 
cut-off level were set as 3 (Supplementary Table 1). 
P-values less than 0.05 were regarded as suggestively significant. Although PD parameters 
were not independent from each other (Supplementary Table 2), conservational significant 
levels of p-values less than 0.017 based on the Bonferroni’s correction were applied. Statistical 
analyses were performed by R statistical software or SPSS. 
 
3.Results 
3.1 Associations between PD and positivity of RF or ACPA 
A total of 9,554 subjects were recruited from the 9,804 participants in the Nagahama study. 
The characteristics of the 9,554 study participants in the current study are summarized in Table 
1 and detailed distributions of PD parameters are shown in Supplementary Table 3. In addition, 
we performed sub-analysis using 6,804 non-smokers among the 9,554 subjects. The detailed 
process of sample exclusion and study design are shown in Supplementary Figure 1. Of the 
participants, 1.7 and 6.4% were positive for ACPA and RF, respectively.  We analyzed whether 
positivity of ACPA and RF were associated with PD parameters in the participants. As a result, 
we found significant or suggestive positive associations between increasing positivity of ACPA 
and all of the PD parameters, namely, MT, CPI and LA conditioned with covariates (p=0.024, 
0.0042 and 0.037, respectively, Table 2). On the contrary, none of the PD parameters revealed 
significant associations with RF positivity (p≥0.19, Table 2). We also presented the association 
results between PD parameters and positivity of ACPA or RF without covariates (Table 2). 
 
3.2 Associations between PD and levels of RF or ACPA 
 Next, whether levels of ACPA and RF are associated with PD parameters was analyzed. We 
observed significant associations between increasing ACPA levels and PD parameters (p≤0.010, 
Supplementary Table 4). Since linearity of quantification of low titers around the lowest 
measuring limit was not fully guaranteed, we classified levels of ACPA and RF into four 
categories (for details, see Materials and Methods and Supplementary Table 1) and performed 
Poisson regression analysis to analyze increasing effects of PD parameters on ACPA and RF 
categorical levels. As a result, we found that PD parameters were significantly associated with 
increasing categorical levels of ACPA (p≤0.00031, Table 2). On the contrary, we did not find 
significant associations between PD parameters and crude or categorical levels of RF (Table 2 
and Supplementary Table 4). Since the positivity of ACPA in the participants is low, linear 
regression model dividing ACPA levels into three groups of ACPA-negative, ACPA-low positive 
and ACPA-high positive resulted in very similar results to qualitative analysis of ACPA in the 
logistic regression models (data not shown). 
 
 Next, we classified PD parameters into four groups according to the severity of PD in order to 
confirm dose-dependent associations of PD parameters on positivity or categorical levels of 
ACPA and RF.  We observed the above-mentioned associations in all combinations of PD 
parameters and positivity or categorical levels of ACPA and RF (Figure 1). CPI was shown to be 
associated with increasing ACPA positivity and levels when CPI was more than 2.  
 
 Finally, we performed a sub-analysis focusing on non-smoking subjects. 6,206 out of 9,554 
subjects (65.0%) were non-smokers (Supplementary Figure 1). We found in the non-smokers 
the same association patterns between PD parameters and positivity or levels of ACPA and RF 
with comparable effect sizes to the results in 9,554 subjects (Supplementary Figure 2, 
Supplementary Table 5 and 6). These results confirmed that the above-mentioned associations 
were not confounded by smoking.  While MT and LA showed suggestive negative associations 
with categorical levels of RF (Supplementary Table 5), these associations were not clear for 
log-transformed RF (Supplementary Table 6) and CPI did not show a significant association.  
  
4.Discussion 
9,575 healthy subjects without connective tissue diseases were selected in this study. The 201 
subjects excluded from the current study due to possibility of having connective tissue diseases 
were 2.1% of the Nagahama Study participants and 27.9, 34.8 and 70.1% of them were positive 
for ACPA, RF, and anti-nuclear antibody, respectively. The percentage of excluded samples 
seems reasonable considering prevalence of RA and safety margin to avoid contamination of 
patients with RA in the current study.  We did not have information of sicca syndrome in the 
current study. However, considering high positivity of RF and low positivity of ACPA in 
subjects with sicca syndrome or Sjögren syndrome[20, 21], the association with ACPA and lack 
of association with RF cannot be explained by subjects with undiagnosed sicca or Sjögren 
syndrome. 
 
This is the first study ever to analyze the association between PD parameters and positivity or 
levels of ACPA and RF in a large-scale healthy population. We found significant associations 
between PD parameters and positivity or levels of ACPA, but not between PD parameters and 
positivity or levels of RF. These association patterns were also observed in non-smokers. The 
beta values of PD parameters on ACPA levels or positivity were not strong. However, since the 
positivity of ACPA in healthy subjects is very low, it is not realistic to assume a one-to-one 
association between ACPA and common factors such as PD. Thus, it is important to accumulate 
enough number of subjects to identify weak to moderate but significant associations between 
common factors and rare phenotypes. 
 
Since detailed data for PD parameters in sextants were available, we adopted average CPI and 
LA as dependent variables which were expected to precisely reflect periodontal inflammation. 
  The covariates in the current study were selected based on previous studies and included 
major common covariates in the previous studies. While we did not have detailed 
socioeconomic data for the participants, we used the current working status as a covariate. 
Inclusion of people over 60 years old in the Nagahama study and the higher ratio of females in 
the participants might lead to increased ratio of unemployed population because many Japanese 
companies set retirement age as 60 and we categorized house wives as “unemployed”. A 
previous study showed that socioeconomic status in the Japanese population was not necessarily 
associated with disease risk observed in other countries due to the wide coverage of national 
health insurance system[22], so the influence of insufficient socioeconomic status in the current 
study should be minimal. 
Since shared epitope (SE), a susceptibility HLA-DRB1 allelic group, was not associated with 
ACPA and RF in our previous study[17], we did not use SE as a covariate. The associations of 
PD with ACPA or RF did not change in condition with SE when we analyzed 3,169 participants 
whose SE information were available (data not shown).  
 
Considering the high specificity of ACPA and PD as a potential cause of RA, the positive 
association found in the current study may suggest that PD is associated with the production of 
ACPA and triggers the development of RA. It is interesting that we did not observe significant 
associations between PD parameters and RF positivity or levels. Not even a trend in increasing 
effects of PD parameters was observed on RF positivity and levels. We did find instead 
suggestive negative associations between LA or MT and categorical levels of RF in 
non-smokers, but the associations were inconclusive. Since RF positivity is much higher than 
that of ACPA, the lack of significant positive associations of RF cannot be explained by 
frequency. Involvement of PD with the process of ACPA production and not with that of RF 
could be a reasonable explanation. Although P gingivalis is a promising candidate to explain the 
involvement of PD with ACPA production, there is not yet enough evidence to conclude that P 
gingivalis in the PD-related bacterial flora is the cause of increasing positivity and level of 
ACPA. A recent study suggested that fine-specific ACPA detected in healthy subjects may not 
be specific to citrullinated peptide[23]. There is a possibility that non-specific oral inflammation 
by PD is important for ACPA production through undetermined processes. While we do not 
have data of anti-P gingivalis antibody, a large-scale association study of healthy population 
with anti-P gingivalis antibody would conclude that the increasing effects of PD on ACPA is 
associated with nonspecific PD or PD caused by P gingivalis.  
Recent studies have revealed that correlates of ACPA are different according to fine fractions 
of ACPA[24], and it will be interesting to quantify detailed fractions of ACPA in the study 
participants and compare the results among fractions of ACPA. It is feasible to replicate these 
results in other populations including Europeans.  
 
5.Conclusions 
 ACPA positivity and levels are associated with PD in a healthy population. This association 
would support involvement of PD in the process of production of ACPA. 
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Figure 1. Significant associations of PD parameters with positivity and levels of ACPA but not with 
those of RF. 
Y axes for categorical levels indicate adjusted levels by covariates. 
P-values of logistic regression analysis or Poisson regression analysis in condition with covariates 
are indicated. 
NS: not significant (p>0.05), MT:the number of missing teeth, CPI:the Community Periodontal 








Female ratio 66.9% 
Age* 53.29±13.43 
MT** 0-28 (1) 
CPI** 0-4 (0.833) 
LA** 0-4 (0) 
ACPA positivity 1.7% 
ACPA category 0:7395, 1:1992, 2:100, 3:67 
RF positivity 6.4% 
RF category 0:6357, 1:2583, 2:486, 3:128 
Body mass index* 22.30±3.28 
Smoking Smoker:3348, Non-smoker:6206 
Alcohol drinking Drinker:6134, Non-drinker:3419 
Current working status*** Full-time:3013, Part-time:2052, Unemployed:4489 
History of DM 5.2% 
Usage of insulin 0.3% 
Usage of anti-hyperglycaemic medications 2.8% 
MT:the number of missing teeth, CPI:the Community Periodontal Index, LA: Loss of 
Attachment, ACPA:anti-citrullinated peptide antibody, RF:rheumatoid factor 
*Mean±standard deviation 
**minimum-maximum (median)  
***house wife is categorized as unemployed 
Table 2. PD parameters, especially CPI are associated with positivity and levels of ACPA but not 
with those of RF. 
 
ACPA positivity ACPA categorical levels RF positivity RF categorical levels 
PD parameters OR (95%CI) P Beta SE P OR (95%CI) P Beta SE P 
Unadjusted           
MT 1.04 (1.02-1.06) 8.0x10-5 0.019 0.0030 6.2x10-10 1.00 (0.98-1.01) 0.81 -0.0037 0.0028 0.18 
CPI 1.31 (1.15-1.48) 2.0x10-5 0.111 0.017 1.9x10-10 1.01 (0.94-1.09) 0.70 0.0068 0.014 0.64 
LA 1.28 (1.12-1.46) 0.00033 0.126 0.020 2.5x10-10 0.97 (0.88-1.07) 0.54 -0.017 0.018 0.36 
Adjusted           
MT 1.03 (1.00-1.05) 0.024 0.013 0.0035 0.00031 0.99 (0.98-1.01) 0.27 -0.0043 0.0032 0.17 
CPI 1.23 (1.07-1.42) 0.0042 0.081 0.020 5.4x10-5 1.00 (0.92-1.09) 0.98 0.015 0.016 0.37 
LA 1.18 (1.01-1.37) 0.037 0.088 0.022 9.2x10-5 0.93 (0.84-1.03) 0.19 -0.016 0.020 0.43 
ACPA:anti-citrullinated peptide antibody, RF:rheumatoid factor, PD:periodontal disease, 
MT:the number of missing teeth, CPI:the Community Periodontal Index, LA:Loss of 
Attachment, OR:odds ratio, CI:confidence interval, SE:standard error 
 
 
F i g u r e  1
Supplementary Figure 1. Flow of the current study. 
 
A schematic view of sample exclusion and data analysis is indicated. 
Supplementary Figure 2. Associations between PD parameters and positivity or levels of ACPA 
and RF in non-smokers. 
 
Y axes for categorical levels indicate adjusted levels by covariates. 
P-values of logistic regression analysis or Poisson regression analysis in condition with covariates 
are indicated. 
NS: not significant (p>0.05), MT:the number of missing teeth, CPI:the Community Periodontal 
Index, LA: Loss of Attachment, ACPA:anti-citrullinated peptide antibody, 
RF:rheumatoid factor 
 
Supplementary Table 1. Distributions of subjects in the current study according to 
categorical levels of ACPA and RF. 
ACPA 
    
Positivity Negative Positive 
Levels ACPA<0.6 0.6≤ACPA <4.5U/ml 4.5≤ACPA<13.5U/ml 13.5U/ml≤ACPA 
Categorical levels 0 1 2 3 
Number of subjects 7,395 1,992 100 67 
     RF 
    
Positivity Negative Positive 
Levels RF=1IU/ml 1<RF≤20IU/ml 20<RF≤60IU/ml 60IU/ml <RF 
Categorical levels 0 1 2 3 
Number of subjects 6,357 2,583 486 128 
 
Supplementary Table 2. Correlations between PD parameters. 
 
MT CPI LA 
MT - 
  
CPI 0.49 - 
 
LA 0.62 0.48 - 
 
Supplementary Table 3. Distributions of the study participants according to PD 
parameters. 
MT 0 1-5 6-10 11-15 16-20 21-25 26- 
Subjects 4,301 3,527 809 330 236 150 201 
CPI 0-≤0.5 0.5<-≤1 1<-≤1.5 1.5<-≤2 2<-≤2.5 2.5<-≤3 3<- 
Subjects 4,023 1,793 1,078 804 598 425 833 
LA 0-≤0.5 0.5<-≤1 1<-≤1.5 1.5<-≤2 2<-≤2.5 2.5<-≤3 3<- 
Subjects 7,446 778 410 249 134 165 372 
 
 




ACPA titer RF titer 
 
Beta SE P Beta SE P 
Unadjusted       
MT 0.0055 0.0010 8.3x10-8 -0.0015 0.0020 0.44 
CPI 0.032 0.0054 3.6x10-9 0.0087 0.011 0.41 
LA 0.035 0.0067 1.8x10-7 -0.0068 0.013 0.60 
Adjusted       
MT 0.0030 0.0012 0.010 -0.0024 0.0012 0.28 
CPI 0.020 0.0062 0.00096 0.012 0.012 0.31 
LA 0.020 0.0075 0.0084 -0.0095 0.014 0.51 
ACPA:anti-citrullinated peptide antibody, RF:rheumatoid factor, PD:periodontal disease, 
MT:the number of missing teeth, CPI:the Community Periodontal Index, LA: Loss of 
Attachment, OR:odds ratio, CI:confidence interval, SE:standard error 
 
Supplementary Table 5. The associations between PD parameters and positivity or categorical levels 
of ACPA and RF in non-smoking population. 
 
ACPA positivity ACPA categorical levels RF positivity RF categorical levels 
PD parameters OR (95%CI) P Beta SE P OR (95%CI) P Beta SE P 
Unadjusted           
MT 1.04 (1.01-1.07) 0.0035 0.020 0.0040 4.1x10-7 0.99 (0.97-1.01) 0.19 -0.0088 0.0038 0.022 
CPI 1.26 (1.07-1.49) 0.0050 0.120 0.023 1.5x10-7 0.95 (0.86-1.05) 0.28 -0.016 0.019 0.40 
LA 1.29 (1.08-1.54) 0.0053 0.142 0.026 5.3x10-8 0.87 (0.76-1.00) 0.050 -0.054 0.025 0.032 
Adjusted           
MT 1.03 (1.00-1.06) 0.048 0.018 0.0045 7.0x10-5 0.98 (0.96-1.00) 0.084 -0.0099 0.0043 0.022 
CPI 1.20 (1.00-1.45) 0.049 0.110 0.026 1.9x10-5 0.93 (0.83-1.04) 0.20 -0.012 0.021 0.57 
LA 1.22 (1.00-1.50) 0.048 0.128 0.029 1.1x10-5 0.84 (0.72-0.97) 0.022 -0.055 0.028 0.046 
ACPA:anti-citrullinated peptide antibody, RF:rheumatoid factor, PD:periodontal disease, 
MT:the number of missing teeth, CPI:the Community Periodontal Index, LA: Loss of 
Attachment, OR:odds ratio, CI:confidence interval, SE:standard error 
 
Supplementary Table 6. The associations between PD parameters and titers of ACPA 
and RF in non-smoking population. 
 
ACPA titer RF titer 
 
Beta SE P Beta SE P 
Unadjusted       
MT 0.0057 0.0013 1.3x10-5 -0.0045 0.0026 0.091 
CPI 0.030 0.0070 1.2x10-5 -0.0084 0.014 0.55 
LA 0.038 0.0086 1.4x10-5 -0.033 0.017 0.060 
Adjusted       
MT 0.0046 0.0015 0.0016 -0.0055 0.0030 0.064 
CPI 0.025 0.0077 0.0012 -0.0073 0.016 0.64 
LA 0.031 0.0094 0.0010 -0.036 0.019 0.057 
ACPA:anti-citrullinated peptide antibody, RF:rheumatoid factor, PD:periodontal disease, 
MT:the number of missing teeth, CPI:the Community Periodontal Index, LA: Loss of 
Attachment, OR:odds ratio, CI:confidence interval, SE:standard error 
